Physician profile
Brooke Bauer
NPI 1386088508
$4,522.66
in general payments reported to CMS, 2019-2025
33 companies · $1,083 in 2025
The $1,083 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.21 · 2020: $117 · 2021: $491 · 2022: $579 · 2023: $1,095 · 2024: $1,073 · 2025: $1,083.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,250.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $928.93 | 2023-2025 | Evoke, Evoke Scs |
| Abbott Laboratories | $589.02 | 2021-2025 | Eterna, Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $412.71 | 2021-2025 | Relistor |
| Abbvie INC. | $399.71 | 2021-2024 | Botox, Ubrelvy, Qulipta |
| Boston Scientific Corporation | $394.54 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Medtronic, INC. | $232.39 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Spr Therapeutics, INC | $211.73 | 2023-2025 | Sprint Pns System |
| Teva Pharmaceuticals USA, INC. | $146.50 | 2020-2023 | Austedo, Ajovy |
| Pfizer INC. | $127.49 | 2020-2021 | |
| Si-Bone, INC. | $109.34 | 2021-2024 | |
| Tersera Therapeutics LLC | $99.70 | 2022-2025 | Prialt |
| Averitas Pharma INC. | $84.69 | 2024 | Qutenza |
| Azurity Pharmaceuticals, INC. | $84.37 | 2023-2025 | Horizant, Horizant |
| Avanos Medical | $78.92 | 2024-2025 | Generator |
| Vertex Pharmaceuticals Incorporated | $78.56 | 2024-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $78.33 | 2021-2022 | |
| Medtronic USA, INC. | $67.50 | 2019 | |
| Protega Pharmaceutials INC | $52.45 | 2022 | |
| Allergan, INC. | $43.88 | 2021-2022 | |
| Lilly USA, LLC | $38.35 | 2021 | |
| Vertos Medical, INC. | $27.99 | 2024 | Mild Device Kit |
| Nevro Corp. | $26.70 | 2021-2022 | |
| Krystal Biotech INC | $23.24 | 2025 | Vyjuvek |
| Lundbeck LLC | $22.74 | 2025 | Vyepti |
| Valinor Pharma, LLC | $22.52 | 2025 | Movantik |
| Scilex Pharmaceuticals INC. | $21.98 | 2022 | |
| Mdd US Operations, LLC | $21.38 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.63 | 2025 | Iovera |
| Mml US, INC. | $18.19 | 2025 | Reactiv8 |
| Collegium Pharmaceutical, INC. | $17.52 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $15.90 | 2025 | Dysport |
| Arbor Pharmaceuticals, INC. | $14.84 | 2021 | |
| Zyla Life Sciences, INC. | $11.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.